Home / Inspections / 1041173

FDA Inspection 1041173 — Biomat USA Inc

Biomat USA Inc — FEI 1000522112

The FDA completed an inspection of Biomat USA Inc on February 2, 2018 in Cleveland, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 2, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Cleveland, OH (United States)

Facility

Other inspections at this facility

  • 1114622 (NAI Fri Dec 20 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 913423 (NAI Wed Feb 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 816496 (VAI Thu Jan 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 706463 (NAI Thu Jan 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 694728 (NAI Wed Oct 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources